In the study population, the new syncope score detected patients with an increased risk of death after discharge from a syncopal event. Our score predicted adverse events comparably to other scores reported in the literature. It has the advantage of being simple and easily obtained from the history and an inexpensive noninvasive test-the ECG.
Agenesis of the inferior vena cava is a rare malformation. Its most common cause is dysgenesis during embryogenesis, but it may also be related to intrauterine or perinatal thrombosis. It is usually asymptomatic, associated or not with other congenital malformations and may be related to increased risk of chronic venous insufficiency and deep vein thrombosis, especially in young individuals. Diagnosis is often incidental, during abdominal surgery or radiological procedures. We reported five cases of agenesis of the inferior vena cava detected during electrophysiological procedures.
BackgroundThe International Commission of Radiology recommends a pregnancy screening test to
all female patients of childbearing age who will undergo a radiological study.
Radiation is known to be teratogenic and its effect is cumulative. The teratogenic
potential starts at doses close to those used during these procedures. The
prevalence of positive pregnancy tests in patients undergoing electrophysiological
studies and/or catheter ablation in our midst is unknown. ObjectiveTo evaluate the prevalence of positive pregnancy tests in female patients referred
for electrophysiological study and/or radiofrequency ablation. MethodsCross-sectional study analyzing 2,966 patients undergoing electrophysiological
study and/or catheter ablation, from June 1997 to February 2013, in the Institute
of Cardiology of Rio Grande do Sul. A total of 1490 procedures were performed in
women, of whom 769 were of childbearing age. All patients were screened with a
pregnancy test on the day before the procedure. ResultsThree patients tested positive, and were therefore unable to undergo the
procedure. The prevalence observed was 3.9 cases per 1,000 women of childbearing
age. ConclusionBecause of their safety and low cost, pregnancy screening tests are indicated for
all women of childbearing age undergoing radiological studies, since the degree of
ionizing radiation needed for these procedures is very close to the threshold for
teratogenicity, especially in the first trimester, when the signs of pregnancy are
not evident.
CONTEXT AND OBJECTIVE: Occurrences of asymptomatic atrial fibrillation (AF) are common. It is important to identify AF because it increases morbidity and mortality. 24-hour Holter has been used to detect paroxysmal AF (PAF). The objective of this study was to investigate the relationship between occurrence of PAF in 24-hour Holter and the symptoms of the population studied. DESIGN AND SETTING: Cross-sectional study conducted at a cardiology hospital. METHODS: 11,321 consecutive 24-hour Holter tests performed at a referral service were analyzed. Patients with pacemakers or with AF throughout the recording were excluded. RESULTS: There were 75 tests (0.67%) with PAF. The mean age was 67 ± 13 years and 45% were female. The heart rate (HR) over the 24 hours was a minimum of 45 ± 8 bpm, mean of 74 ± 17 bpm and maximum of 151 ± 32 bpm. Among the tests showing PAF, only 26% had symptoms. The only factor tested that showed a correlation with symptomatic AF was maximum HR (165 ± 34 versus 147 ± 30 bpm) (P = 0.03). Use of beta blockers had a protective effect against occurrence of PAF symptoms (odds ratio: 0.24, P = 0.031). CONCLUSIONS: PAF is a rare event in 24-hour Holter. The maximum HR during the 24 hours was the only factor correlated with symptomatic AF, and use of beta blockers had a protective effect against AF symptom occurrence.
RESUMO
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.